Heron Therapeutics | HRTX - Pe Prix À Revenus





Pe Changement Date
ALKERMES 19.54 4.64 2025-12
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Amarin 91.05 88.3 2023-06
ANI Pharmaceuticals 37.99 60.68 2025-12
Anika Therapeutics 47.54 27.2 2024-06
Eisai 26.63 0.46 2025-12
Emergent BioSolutions 14.4 2.25 2022-09
Esperion Therapeutics 129.79 129 2024-12
GlaxoSmithKline 11.15 0.29 2025-12
Heron Therapeutics 6.46 3.23 2006-12
Ligand Pharmaceuticals 60.65 17.62 2025-09
Merck 13.92 5.08 2025-12
Neurocrine Biosciences 835.47 802.2 2025-12
Pacira 52.68 23.44 2025-12
Regeneron Pharmaceuticals 18.11 2.91 2025-12
Roche Holding 16.09 3.51 2025-12
Surmodics 386.18 225.66 2021-12
Veracyte 45.3 5.4 2025-12
Vertex Pharmaceuticals 26.15 2.22 2025-12